During the past decade, Ottawa Hospital Research Institute conducted 158 clinical trials. In the 10-year time frame, 158 clinical trials started and 52 clinical trials were completed, i.e. on average, 32.9% percent of trials that started reached the finish line to date. In the past 5 years, 68 clinical trials started and 35 clinical trials were completed. i.e. 51.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ottawa Hospital Research Institute" #1 sponsor was "Ottawa Hospital Research Institute" with 69 trials, followed by "Canadian Cancer Trials Group" with 50 trials sponsored, "NCIC Clinical Trials Group" with 27 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored and "National Cancer Institute (NCI)" with 7 trials sponsored. Other sponsors include 95 different institutions and companies that sponsored additional 72 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ottawa Hospital Research Institute" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 23 trials as a collaborator, "AstraZeneca" with 16 trials as a collaborator, "National Cancer Institute (NCI)" with 11 trials as a collaborator, "Ottawa Hospital Research Institute" with 9 trials as a collaborator and "SWOG Cancer Research Network" with 8 trials as a collaborator. Other collaborators include 283 different institutions and companies that were collaborators in the rest 207 trials.

According to Clinical.Site data, the most researched conditions in "Ottawa Hospital Research Institute" are "Breast Cancer" (16 trials), "Prostate Cancer" (14 trials), "Lung Cancer" (9 trials), "Cancer" (7 trials) and "Colorectal Cancer" (6 trials). Many other conditions were trialed in "Ottawa Hospital Research Institute" in a lesser frequency.

Most popular intervention types in "Ottawa Hospital Research Institute" are "Drug" (160 trials), "Other" (46 trials), "Procedure" (24 trials), "Biological" (23 trials) and "Radiation" (19 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Durvalumab" (11 trials), "Pembrolizumab" (8 trials), "Cisplatin" (7 trials) and "Tremelimumab" (7 trials). Other intervention names were less common.

The vast majority of trials in "Ottawa Hospital Research Institute" are 222 trials for "All" genders, 20 trials for "Female" genders and 17 trials for "Male" genders.

Currently, there are NaN active trials in "Ottawa Hospital Research Institute". 6 are not yet recruiting, 47 are recruiting, 42 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 125 completed trials in Ottawa Hospital Research Institute, undefined suspended trials, and 22 terminated clinical trials to date.

Out of the total trials that were conducted in Ottawa Hospital Research Institute, 23 "Phase 1" clinical trials were conducted, 87 "Phase 2" clinical trials and 62 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 41 trials that are defined as “Not Applicable".